Patrick Forde, Professor at The Johns Hopkins University, shared a post on X:
“A big day for cancer research, far from cure but the cancer we all dread is slightly less formidable – Daraxonrasib Demonstrates Overall Survival Benefit in Patients with Metastatic Pancreatic Cancer”
Other articles featuring Patrick Forde on OncoDaily.